Back to search
FDAFDA · Food and drugs·Recall number D-500-2013

Ropinirole hydrochloride tablets, USP 4 mg, 100-count bottle (NDC 0378-5504-01), Rx only, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. Made in India

Published June 5, 2013 · Recall initiated: April 22, 2013

Summary

FDA records drug Class II recall D-500-2013, published June 5, 2013 and initiated April 22, 2013. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 3,048 bottles; Lot: Lot # ZRMB11004, Exp 09/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label Error on Declared Strength- Unopened bottles of Ropinirole USP 3 mg tablets was found to be incorrectly labeled as Ropinirole USP 4 mg tablets..

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mylan Pharmaceuticals Inc.
Distributor
Nationwide
Lot
Lot # ZRMB11004, Exp 09/13
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ropinirole hydrochloride tablets, USP 4 mg, 100-count bottle (NDC 0378-5504-01), Rx only, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. Made in India recalled?

Yes. FDA published recall D-500-2013 on June 5, 2013. Reported hazard: Labeling: Label Error on Declared Strength- Unopened bottles of Ropinirole USP 3 mg tablets was found to be incorrectly labeled as Ropinirole USP 4 mg tablets..

What should I do if I have this product?

Voluntary: Firm initiated · Letter